QIAGEN N.V. Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount
QIAGEN N.V. (QGEN) reported Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount of $0 for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-14.
Discontinued › Notes › Investments › Debt and Equity Securities › Equity Securities without Readily Determinable Fair Value, Annual Amount
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount · last filed 2023-03-13
| Period end | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 12 month | Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 12 month as first filed |
|---|---|---|
| 2021-12-31 | $0.00 20-F · filed 2022-03-14 | |
| 2020-12-31 | $400.00K 20-F · filed 2023-03-13 | $398.00K 20-F · filed 2021-03-05 |
| 2019-12-31 | $0.00 20-F · filed 2021-03-05 |